In one of our ongoing international clinical trials in Sjögren’s disease, our Clinical Research Site in Bydgoszcz achieved a Top 3 global ranking in patient randomization.
The study includes more than 60 research sites worldwide, spanning the United States, Argentina, Greece, Spain, and several other countries. Achieving such a result in a highly competitive global study highlights the strength of our site operations and patient access capabilities.
Congratulations to everyone involved in achieving this important milestone. We appreciate the opportunity to contribute to global clinical studies and meaningful research progress.
At Medicover Integrated Clinical Services, we support clinical trials across multiple therapeutic areas, contributing to high-quality data generation and the advancement of clinical research.
Looking for experienced sites for a Sjögren’s disease study?
Contact us to learn how we can support your trial.
